These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29324810)

  • 1. Course of SP-D, YKL-40, CCL18 and CA 15-3 in adult patients hospitalised with community-acquired pneumonia and their association with disease severity and aetiology: A post-hoc analysis.
    Spoorenberg SMC; Vestjens SMT; Voorn GP; van Moorsel CHM; Meek B; Zanen P; Rijkers GT; Bos WJW; Grutters JC;
    PLoS One; 2018; 13(1):e0190575. PubMed ID: 29324810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YKL-40, CCL18 and SP-D predict mortality in patients hospitalized with community-acquired pneumonia.
    Spoorenberg SM; Vestjens SM; Rijkers GT; Meek B; van Moorsel CH; Grutters JC; Bos WJ;
    Respirology; 2017 Apr; 22(3):542-550. PubMed ID: 27782361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Study of Circulating MMP-7, CCL18, KL-6, SP-A, and SP-D as Disease Markers of Idiopathic Pulmonary Fibrosis.
    Hamai K; Iwamoto H; Ishikawa N; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Ohshimo S; Fujitaka K; Hamada H; Hattori N; Kohno N
    Dis Markers; 2016; 2016():4759040. PubMed ID: 27293304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of serum biomarkers between patients with asthma and with chronic obstructive pulmonary disease.
    Han SS; Lee WH; Hong Y; Kim WJ; Yang J; Lim MN; Lee SJ; Kwon JW
    J Asthma; 2016 Aug; 53(6):583-8. PubMed ID: 27104648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of plasma YKL-40 in management of community-acquired pneumonia severity in patients.
    Wang HL; Hsiao PC; Tsai HT; Yeh CB; Yang SF
    Int J Mol Sci; 2013 Nov; 14(11):22817-25. PubMed ID: 24256818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YKL-40 levels are associated with disease severity and prognosis of viral pneumonia, but not available in bacterial pneumonia in children.
    Yang X; Sheng G
    BMC Pediatr; 2018 Dec; 18(1):381. PubMed ID: 30514252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of Serum S100A12 With Severity and Prognosis in Patients With Community-Acquired Pneumonia: A Prospective Cohort Study.
    Jiang X; Huang CM; Feng CM; Xu Z; Fu L; Wang XM
    Front Immunol; 2021; 12():714026. PubMed ID: 34745092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of genetic variability at the surfactant proteins A and D in community-acquired pneumonia: a prospective, observational, genetic study.
    García-Laorden MI; Rodríguez de Castro F; Solé-Violán J; Rajas O; Blanquer J; Borderías L; Aspa J; Briones ML; Saavedra P; Marcos-Ramos JA; González-Quevedo N; Sologuren I; Herrera-Ramos E; Ferrer JM; Rello J; Rodríguez-Gallego C
    Crit Care; 2011; 15(1):R57. PubMed ID: 21310059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of soluble intercellular adhesion molecule-1 as a biomarker for disease severity of patients with community-acquired pneumonia.
    Chang PY; Tsao SM; Chang JH; Chien MH; Hung WY; Huang YW; Yang SF
    Clin Chim Acta; 2016 Dec; 463():174-180. PubMed ID: 27983998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Monocyte Chemoattractant Protein-1 Level as a Predictor of the Severity of Community-Acquired Pneumonia.
    Yong KK; Chang JH; Chien MH; Tsao SM; Yu MC; Bai KJ; Tsao TC; Yang SF
    Int J Mol Sci; 2016 Jan; 17(2):. PubMed ID: 26840299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation between serum vitamin D level and severity of community acquired pneumonia in young children].
    Ren J; Sun B; Miao P; Feng X
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jul; 15(7):519-21. PubMed ID: 23866270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in blood monocyte Toll-like receptor and serum surfactant protein A reveal a pathophysiological mechanism for community-acquired pneumonia in patients with type 2 diabetes.
    Que Y; Shen X
    Intern Med J; 2016 Feb; 46(2):213-9. PubMed ID: 26648341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community-acquired pneumonia requiring hospitalisation. Factors of importance for the short-and long term prognosis.
    Hedlund J
    Scand J Infect Dis Suppl; 1995; 97():1-60. PubMed ID: 8584866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Cytokine and Chemokine Signatures as Potential Biomarkers of Childhood Community-acquired Pneumonia Severity: A Nested Cohort Study in India.
    Saghafian-Hedengren S; Mathew JL; Hagel E; Singhi S; Ray P; Ygberg S; Nilsson A
    Pediatr Infect Dis J; 2017 Jan; 36(1):102-108. PubMed ID: 27956727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community-acquired pneumonia in older patients: does age influence systemic cytokine levels in community-acquired pneumonia?
    Kelly E; MacRedmond RE; Cullen G; Greene CM; McElvaney NG; O'Neill SJ
    Respirology; 2009 Mar; 14(2):210-6. PubMed ID: 19272082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YKL-40, a matrix protein of specific granules in neutrophils, is elevated in serum of patients with community-acquired pneumonia requiring hospitalization.
    Nordenbaek C; Johansen JS; Junker P; Borregaard N; Sørensen O; Price PA
    J Infect Dis; 1999 Nov; 180(5):1722-6. PubMed ID: 10515841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory biomarkers and prediction for intensive care unit admission in severe community-acquired pneumonia.
    Ramírez P; Ferrer M; Martí V; Reyes S; Martínez R; Menéndez R; Ewig S; Torres A
    Crit Care Med; 2011 Oct; 39(10):2211-7. PubMed ID: 21705887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index.
    Masiá M; Gutiérrez F; Shum C; Padilla S; Navarro JC; Flores E; Hernández I
    Chest; 2005 Oct; 128(4):2223-9. PubMed ID: 16236878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant progranulin, YKL-40, cathepsin D and cathepsin S in Gaucher disease.
    Afinogenova Y; Ruan J; Yang R; Kleytman N; Pastores G; Lischuk A; Mistry PK
    Mol Genet Metab; 2019; 128(1-2):62-67. PubMed ID: 31358474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive values of semi-quantitative procalcitonin test and common biomarkers for the clinical outcomes of community-acquired pneumonia.
    Ugajin M; Yamaki K; Hirasawa N; Yagi T
    Respir Care; 2014 Apr; 59(4):564-73. PubMed ID: 24170911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.